CONTENTS:
- Does research into medical education on tobacco and alcohol get the respect it deserves? [Editorial]. Raupach T., Krampe H., Brown J., p. 173-174.
- Reporting quantitative information in qualitative research: guidance for authors and reviewers [Editorial note]. Neale J., Miller P., West R., p. 175-176.
- Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world? [For debate]. Fischer B., Keates A., Bühringer G., Reimer J., Rehm J., p. 177-181.
- The (mis)use of psychoactive medicines: getting the balance right in complex systems. Griffiths P., Evans-Brown M., Sedefov R., p. 182-183.
- Variations in prescription opioids and related harms: a key to understanding and effective policy. Samet J.H., Tsui J.I., p. 183-185.
- Prescription opioid deaths: we need to treat sick populations, not just sick individuals. Rintoul A.C., Dobbin M., p. 185-186.
- Considering prescription opioid-related harms in the population: Response to commentaries. Fischer B., Keates A., Bühringer G., Reimer J., Rehm J., p. 186-188.
- Commentary on Pridemore (2014): Drinking and suicide in Russia - strong evidence of a strong link. Norström T., p. 189-190.
- Reply to Norström (2014): The social epidemiology of alcohol and suicide - the struggle to formulate, debate and test social theory in the context of epidemiology and public health journals. Pridemore W.A., p. 191-192.
- Gambling in Sweden: the cultural and socio-political context. Binde P., p. 193-198.
- Vested Interests in Addiction Research and Policy. The challenge corporate lobbying poses to reducing society's alcohol problems: insights from UK evidence on minimum unit pricing. McCambridge J., Hawkins B., Holden C., p. 199-205.
- Trend analysis and modelling of gender-specific age, period and birth cohort effects on alcohol abstention and consumption level for drinkers in Great Britain using the General Lifestyle Survey 1984-2009. Meng Y., Holmes J., Hill-McManus D., Brennan A., Meier P.S., p. 206-215.
- Commentary on Meng et al. (2014): Diverging alcohol consumption across populations - issues for policy and intervention. Lloyd B., Heilbronn C., p. 216-217.
- Balance - a pragmatic randomized controlled trial of an online intensive self-help alcohol intervention. Brendryen H., Lund I.O., Johansen A.B., Riksheim M., Nesvåg S., Duckert F., p. 218-226.
- Family transitions and changes in drinking from adolescence through mid-life. Staff J., Greene K.M., Maggs J.L., Schoon I., p. 227-236.
- Altered cingulate and insular cortex activation during risk-taking in methamphetamine dependence: losses lose impact. Gowin J.L., Stewart J.L., May A.C., Ball T.M., Wittmann M., Tapert S.F., et al., p. 237-247.
- Commentary on Gowin et al. (2014): Brain is behavior - methamphetamine dependence and recovery. Shoptaw S., p. 248-249.
- Training family members to manage heroin overdose and administer naloxone: randomized trial of effects on knowledge and attitudes. Williams A.V., Marsden J., Strang J., p. 250-259.
- Commentary on Williams et al. (2014): Family matters - new resources for managing opioid overdose with take-home naloxone. Tait R.J., Lenton S., p. 260-261.
- Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study. van Emmerik-van Oortmerssen K., van de Glind G., Koeter M.W.J., Allsop S., Auriacombe M., Barta C., et al., p. 262-272.
- Do societal wealth, family affluence and gender account for trends in adolescent cannabis use? A 30 country cross-national study. ter Bogt T.F.M., de Looze M., Molcho M., Godeau E., Hublet A., Kokkevi A., et al., p. 273-283.
- Towards a comprehensive developmental model of cannabis use disorders. Blanco C., Rafful C., Wall M.M., Ridenour T.A., Wang S., Kendler K.S., p. 284-294.
- Prevalence and associations of quetiapine fumarate misuse among an Australian national city sample of people who regularly inject drugs. Reddel S.E., Bruno R., Burns L., Kirwan A., Lokuge K., Dietze P., p. 295-302.
- Legal substance use and the development of a DSM-IV cannabis use disorder during adolescence: the TRAILS study. Prince van Leeuwen A., Creemers H.E., Verhulst F.C., Vollebergh W.A.M., Ormel J., van Oort F., et al., p. 303-311.
- Commentary on Prince van Leeuwen et al. (2014): Tobacco and cannabis use. Fergusson D.M., Boden J.M., p. 312-313.
- Cost-effectiveness of extended cessation treatment for older smokers. Barnett P.G., Wong W., Jeffers A., Munoz R., Humfleet G., Hall S., p. 314-322.
- Genetic and environmental influences on the ages of drinking and gambling initiation: evidence for distinct aetiologies and sex differences. Richmond-Rakerd L.S., Slutske W.S., Heath A.C., Martin N.G., p. 323-331.
- Commentary on Richmond-Rakerd et al. (2014): Genetic and environmental influences on the ages of drinking and gambling initiation: evidence for distinct aetiologies and sex differences. Garcia F.D., p. 332.
- Waterpipe tobacco labeling and packaging and World Health Organization Framework Convention on Tobacco Control (WHO FCTC): A call for action. Bahelah R., p. 333.
- On the mismatch between population drinking and drink driving. Response to Gjerde et al. Norström T., Rossow I., p. 333-334.